Core Scientific, Inc. (CORZ) Chief Executive Officer Adam Taylor Sullivan reported that 21,839 shares were withheld on October 16, 2026, to satisfy withholding tax obligations upon vesting of previously granted restricted stock units. The transaction was not an open-market sale. His reported direct holdings following the transaction were 4,391,079 shares; the reported price was $14.4550 per share.
Core Scientific, Inc. Chief Legal and Administrative Officer Todd M. Duchene sold 10,000 shares on October 19, 2026, at a weighted average price of $13.8744 per share under a Rule 10b5-1 trading plan adopted December 5, 2025; transaction prices ranged from $13.62 to $14.14, inclusive.
On October 16, 2026, 6,382 shares were withheld to satisfy tax obligations upon vesting of previously granted restricted stock units, not as an open-market sale. Duchene also reported 700,000 shares held indirectly by a grantor retained annuity trust of which he is sole trustee.
Core Scientific, Inc. (CORZ) Chief Legal and Administrative Officer Todd M. Duchene sold 10,000 common shares on October 12, 2026, at a weighted average price of $15.1160 per share; the shares were sold in multiple transactions ranging from $14.98 to $15.40. The sale was made under a Rule 10b5-1 trading plan adopted December 5, 2025. After the sale, he held 1,159,668 shares directly. A grantor retained annuity trust of which he is sole trustee held 700,000 shares.
Core Scientific, Inc. common stock is the subject of a proposed sale of 140,000 shares for the account of the Todd DuChene Revocable Trust, with an aggregate market value of $2,157,400.00. Morgan Stanley Smith Barney LLC is named as broker and NASDAQ as the sale venue. Todd DuChene is identified as an officer. The notice also lists prior sales by the trust under 10b5-1, including 10,000 shares on October 5, 2026.
Todd M. Duchene, Core Scientific, Inc.’s Chief Legal and Administrative Officer, sold 10,000 common shares on October 5, 2026, at a weighted average of $16.3056 per share under a Rule 10b5-1 trading plan adopted December 5, 2025. The shares were sold in multiple transactions at prices ranging from $15.90 to $16.75. Following the sale, Duchene held 1,169,668 shares directly; a grantor retained annuity trust of which he is sole trustee held 700,000 shares.
On October 1, 2026, Core Scientific, Inc. CEO Adam Taylor Sullivan had 23,508 shares withheld to satisfy tax obligations when previously granted restricted stock units vested; this was not an open-market sale. The reported price was $15.98 per share, and his direct holdings afterward were 4,412,918 shares.
Core Scientific, Inc. Chief Legal and Administrative Officer Todd M. Duchene had 8,228 shares withheld on October 1, 2026, to satisfy tax obligations upon vesting of previously granted restricted stock units; the reported price was $15.98 per share. The withholding was not an open-market sale. After the transaction, he directly held 1,179,668 shares; a grantor retained annuity trust of which he is sole trustee held 700,000 shares indirectly.
Core Scientific, Inc. Chief Legal and Administrative Officer Todd M. Duchene reported selling 10,000 shares of common stock on September 28, 2026, at a weighted average price of $16.7586 per share. The shares were sold in multiple transactions at prices ranging from $16.44 to $17.20 under a Rule 10b5-1 trading plan adopted December 5, 2025. After the sale, Duchene directly held 1,187,896 shares; 700,000 shares were held by a grantor retained annuity trust for which he is sole trustee.
Core Scientific, Inc. (CORZ) Chief Legal and Administrative Officer Todd M. Duchene sold 10,000 shares on September 21, 2026, at a weighted average price of $18.3746 per share. The shares were sold in multiple transactions at prices ranging from $17.81 to $18.64, inclusive.
The sale was made under a Rule 10b5-1 trading plan adopted December 5, 2025. Duchene reported 1,197,896 shares held directly following the sale. A separate holding entry lists 700,000 shares held by a grantor retained annuity trust of which he is the sole trustee.
Core Scientific, Inc. (CORZ) director Eric Stanton Weiss purchased 6,000 shares of Common Stock on September 15, 2026, in a purchase classified as an open market or private transaction at $16.33 per share. Following this trade, he directly holds 265,262 shares of Core Scientific common stock. No Rule 10b5-1 trading plan is reported for this transaction.